BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20435660)

  • 41. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less.
    Kobayashi N; Toyooka S; Soh J; Ichimura K; Yanai H; Suehisa H; Ichihara S; Yamane M; Aoe M; Sano Y; Date H
    J Thorac Oncol; 2007 Sep; 2(9):808-12. PubMed ID: 17805057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
    Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
    Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.
    Seok Y; Jeong JY; Lee E
    Thorac Cancer; 2017 May; 8(3):197-202. PubMed ID: 28220643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.
    Yoshida J; Nagai K; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Aug; 4(8):959-63. PubMed ID: 19458555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer.
    Maurizi G; D'Andrilli A; Ciccone AM; Ibrahim M; Andreetti C; Tierno S; Poggi C; Menna C; Venuta F; Rendina EA
    Ann Thorac Surg; 2015 Sep; 100(3):918-24; discussion 924-5. PubMed ID: 26209486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery.
    Yun JK; Kim MA; Choi CM; Choi SH; Kim YH; Kim DK; Park SI; Kim HR
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):142-149. PubMed ID: 26669768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pattern of recurrence after curative resection of local (stage I and II) non-small cell lung cancer: difference according to the histologic type.
    Choi YS; Shim YM; Kim K; Kim J
    J Korean Med Sci; 2004 Oct; 19(5):674-6. PubMed ID: 15483342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
    Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.
    Kelsey CR; Higgins KA; Peterson BL; Chino JP; Marks LB; D'Amico TA; Varlotto JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):768-773.e1. PubMed ID: 23856204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T1aN0M0 and T1bN0M0 non-small cell lung cancer: a retrospective study of the prognosis.
    Zhang Z; Wang A; Zhan Z; Sun L; Chen K; Wang C
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):109-16. PubMed ID: 23225513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stage IB nonsmall cell lung cancers: are they all the same?
    Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
    Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.